Edward Nirenberg on Nostr: In the case of GSK, the preterm births occurred early enough that the outcomes were ...
In the case of GSK, the preterm births occurred early enough that the outcomes were very poor for the infants in question, including deaths, causing them to abandon the development of their vaccine for use in pregnancy. Pfizer, however, had more complicated data.
Published at
2024-07-09 14:41:28Event JSON
{
"id": "195c1ad9074c5e17e740e517bd0904ee790454271f2e8c9fcb13d64fae54ad84",
"pubkey": "c67b38e4c5023e985f04ae7ab6a6669cf463220e1b9ed54b897d1957004603a4",
"created_at": 1720536088,
"kind": 1,
"tags": [
[
"e",
"a5a0b367c8be97fec0641784afc66baff520424a890e85f1a892d44ee144c126",
"wss://relay.mostr.pub",
"reply"
],
[
"proxy",
"https://med-mastodon.com/users/enirenberg/statuses/112757053096248206",
"activitypub"
]
],
"content": "In the case of GSK, the preterm births occurred early enough that the outcomes were very poor for the infants in question, including deaths, causing them to abandon the development of their vaccine for use in pregnancy. Pfizer, however, had more complicated data.",
"sig": "422bdc663ca6346a47257e94921d468c97a52a0cded1def00f61ee3af05614d919f11d67c7c3ad5e6becde610c1d08b2b356a945d13bcdc57712ad694755b8d2"
}
